Abstract:Evolutionary Bioinformatics, Volume 18, Issue , January-December 2022. CRISPR-Cas systems are an adaptive immunity that protects prokaryotes against foreign genetic elements. Genetic templates acquired during past infection events enable DNA-interacting enzymes to recognize foreign DNA for destruction. Due to the programmability and specificity of these genetic templates, CRISPR-Cas systems are potential alternative antibiotics that can be engineered to self-target antimicrobial resistance genes on the chromosome or plasmid. However, several fundamental questions remain to repurpose these tools against drug-resistant bacteria. For endogenous CRISPR-Cas self-targeting, antimicrobial resistance genes and functional CRISPR-Cas systems have to co-occur in the target cell. Furthermore, these tools have to outplay DNA repair pathways that respond to the nuclease activities of Cas proteins, even for exogenous CRISPR-Cas delivery. Here, we conduct a comprehensive survey of CRISPR-Cas genomes. First, we address the co-occurrence of CRISPR-Cas systems and antimicrobial resistance genes in the CRISPR-Cas genomes. We show that the average number of these genes varies greatly by the CRISPR-Cas type, and some CRISPR-Cas types (IE and IIIA) have over 20 genes per genome. Next, we investigate the DNA repair pathways of these CRISPR-Cas genomes, revealing that the diversity and frequency of these pathways differ by the CRISPR-Cas type. The interplay between CRISPR-Cas systems and DNA repair pathways is essential for the acquisition of new spacers in CRISPR arrays. We conduct simulation studies to demonstrate that the efficiency of these DNA repair pathways may be inferred from the time-series patterns in the RNA structure of CRISPR repeats. This bioinformatic survey of CRISPR-Cas genomes elucidates the necessity to consider multifaceted interactions between different genes and systems, to design effective CRISPR-based antimicrobials that can specifically target drug-resistant bacteria in natural microbial communities.

Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria

A matter of background: DNA repair pathways as a possible cause for the sparse distribution of CRISPR-Cas systems in bacteria

Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials

Classification and evolution of type II CRISPR-Cas systems

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system

A CRISPR-Nonhomologous End-Joining-based strategy for rapid and efficient gene disruption in

Endogenous Gene Regulation as a Predicted Main Function of Type I-E CRISPR/Cas System in E. coli

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea

Crosstalk between three CRISPR-Cas types enables primed type VI-A adaptation in Listeria seeligeri

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

The stress of carrying CRISPR-Cas

The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system

The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems